- Home
- CRBP vs KRMD Comparison
CRBP vs KRMD Comparison
Compare CRBP & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- KRMD
- Stock Information
- Founded
- CRBP 2009
- KRMD 1980
- Country
- CRBP United States
- KRMD United States
- Employees
- CRBP 19
- KRMD N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- KRMD Medical/Dental Instruments
- Sector
- CRBP Health Care
- KRMD Health Care
- Exchange
- CRBP Nasdaq
- KRMD Nasdaq
- Market Cap
- CRBP 158.3M
- KRMD 182.0M
- IPO Year
- CRBP N/A
- KRMD N/A
- Fundamental
- Price
- CRBP $13.00
- KRMD $3.99
- Analyst Decision
- CRBP Strong Buy
- KRMD Strong Buy
- Analyst Count
- CRBP 8
- KRMD 4
- Target Price
- CRBP $62.00
- KRMD $4.13
- AVG Volume (30 Days)
- CRBP 313.3K
- KRMD 80.9K
- Earning Date
- CRBP 11-07-2024
- KRMD 11-13-2024
- Dividend Yield
- CRBP N/A
- KRMD N/A
- EPS Growth
- CRBP N/A
- KRMD N/A
- EPS
- CRBP N/A
- KRMD N/A
- Revenue
- CRBP N/A
- KRMD $31,993,796.00
- Revenue This Year
- CRBP N/A
- KRMD $17.79
- Revenue Next Year
- CRBP N/A
- KRMD $15.73
- P/E Ratio
- CRBP N/A
- KRMD N/A
- Revenue Growth
- CRBP N/A
- KRMD 11.57
- 52 Week Low
- CRBP $5.25
- KRMD $1.98
- 52 Week High
- CRBP $61.90
- KRMD $4.60
- Technical
- Relative Strength Index (RSI)
- CRBP 25.10
- KRMD 50.77
- Support Level
- CRBP $12.90
- KRMD $3.85
- Resistance Level
- CRBP $16.21
- KRMD $4.60
- Average True Range (ATR)
- CRBP 0.95
- KRMD 0.30
- MACD
- CRBP -0.16
- KRMD -0.07
- Stochastic Oscillator
- CRBP 1.69
- KRMD 19.63
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).